Chemical Structure (Pregabalin 01)
Pregabalin Capsule
Product Images NDC 71205-677
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71205-677). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 (Pregabalin 02)
Figure 2 (Pregabalin 03)
This is a table showing the percentage improvement in pain from baseline for patients taking Pregabai 100 mg (dosage is not specified) once a day. However, the table seems incomplete as there are some numbers listed without clear labels or units.*
Figure 3 (Pregabalin 04)
Figure 4 (Pregabalin 05)
This appears to be a table showing the percent of patients improved with Pregabalin 200 mg three times a day, Pregabalin 100 mg three times a day, and Placebo. The second row shows the percentage of improvement in pain from baseline.*
Figure 5 (Pregabalin 06)
This is a chart displaying the percent improvement in pain from baseline for patients taking either Pregabalin 100 mg three times a day, Pregabalin 50 mg three times a day, or a placebo. The x-axis shows the range of percent improvement from 0 to 100, while the y-axis displays the number of patients who experienced that percent improvement.*
Figure 6 (Pregabalin 07)
Figure 7 (Pregabalin 08)
The text seems to be reporting the seizure reduction in median percentage change in four different studies (E1 BID, E2TID, E3 BID, and E3 TID) using a medication called "Pacabo" at different doses (not specified in the text). However, the actual percentage values and any additional information are not available in the text.*
Figure 9 (Pregabalin 09)
The text describes a chart showing the percentage of patients who improved on various doses of pregabalin compared to a placebo. It also shows the percentage improvement in pain from the baseline.*
Figure 10 (Pregabalin 10)
Figure 11 (Pregabalin 11)
Figure 12 (Pregabalin 12)
71205-677-60 (Pregabalin 15)
This appears to be a product label for a medication called "pregabalin." The medication comes in the form of 75mg capsules and the label warns to keep it out of reach of children. It is also labeled as a prescription medication and includes a product ID. There is a mention of a "Medication Guide" that should be given to each patient. The rest of the text appears to be garbled and unable to be deciphered.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
